MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: AllgemeineskmqacaAntwortenAntworten: kmqaca <blockquote><div class="quotetitle">Zitat von Gast am 31. März 2026, 11:12 Uhr</div>Hello! This post was created with XRumer 23 StrongAI. Good luck :) https://www.nba.com/ [url=https://tsn.ua/ru ]Basketball2[/url] variant4 [url=]Zoya Demidenko[/url]: Researcher in Oncology Science [url=]Zoya Demidenko[/url] is a recognized researcher connected with the Division of Cell Stress Biology at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Earlier, she worked at the National Institutes of Health and New York Medical College, building a strong background in biomedical research. Demidenko's scholarly work encompasses several pivotal domains, among them the PI3K/AKT/mTOR signaling pathway, cellular cycle management, cellular aging, and cancer biology. To date, she has co-authored over 46 scientific articles, which have garnered upwards of 4,100 citations — a testament to the significance of her research. Among her most notable contributions concerns explaining the mechanisms of cellular senescence. Her work revealed that when the cell cycle is halted yet cellular expansion continues, cells experience senescence. Importantly, [url=]Zoya Demidenko[/url] showed that this process can be controlled with drugs using compounds such as rapamycin. [url=]Zoya Demidenko[/url] has also brought substantially to tumor management research, especially in the area of selective cell protection — a approach designed to protecting normal cells from cytotoxic treatment while leaving cancer cells susceptible. This strategy carries significant potential for reducing the side effects of oncological therapy. Throughout her professional journey, Demidenko has worked with top investigators worldwide, such as Dr. Mikhail Blagosklonny. Her publications can be found in prestigious periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.</blockquote><br> Abbrechen
